Periwell
Category: VasomotorClinical Profile

Hot Flashes

Sudden, intense waves of heat — usually over the face, neck, and chest — lasting 1 to 5 minutes and leaving you flushed, damp, and disoriented.

Biological Mechanism

Estrogen acts on the hypothalamus to maintain a stable body temperature within a 'thermoneutral zone.' During perimenopause, erratic estrogen fluctuations (not a steady decline — the swings are what cause the symptoms) narrow this zone dramatically. The hypothalamus then triggers a heat-dissipation response — vasodilation, sweating, increased heart rate — at perfectly normal body temperatures. The trigger is estrogen fluctuation, not low estrogen per se, which is why hot flashes often peak during Late Transition (Stage -1) when swings are most extreme, rather than in postmenopause when estrogen has stabilised at a low level.

Common Misdiagnoses

Anxiety disorder (flushing can be confused for a panic response), Carcinoid syndrome (rare but should be excluded if typical features absent), Pheochromocytoma (very rare), Hyperthyroidism, Rosacea (facial flushing component)

Evidence-Based Treatments

  • 01Transdermal estradiol

    The most effective intervention available — reduces hot flash frequency by 75–85% in most trials. Transdermal route (patch, gel, spray) preferred for cardiovascular safety over oral estrogen.

  • 02Oral micronized progesterone

    Used with estradiol if uterus is present. May have independent benefit for hot flashes via central mechanisms.

  • 03Fezolinetant (Veozah)

    First-in-class neurokinin 3 receptor antagonist — non-hormonal, FDA-approved 2023. Acts on same hypothalamic pathway without hormone involvement.

  • 04Venlafaxine (SNRI)

    Reduces hot flash frequency by ~50%. Appropriate when HRT is contraindicated. Note: paroxetine interacts with tamoxifen (avoid in breast cancer survivors).

  • 05Clonidine

    Modest effect; side effects (hypotension) limit use. Third-line.